Jianguo Huang, Ph.D.

Jianguo Huang

Assistant member, Preclinical Cancer Therapy Laboratory
Earle A. Chiles Research Institute 
Providence Cancer Institute

Contact Dr. Huang 

 

Dr. Huang is a scientist with expertise in cell therapy, preclinical mouse modeling and gene editing. Currently, he leads the Preclinical Cancer Therapy Laboratory at the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy.

Dr. Huang’s career focus has been on addressing the need to improve therapeutic strategies for treating sarcomas. He has a background in cancer biology and non-coding segments of the genome, and expertise in generating sophisticated, genetically engineered tumor models. He was awarded a K22 grant in 2020 by the National Institutes of Health (NIH) to study the coding genes and non-coding RNAs that regulate sarcoma development and metastasis and utilize the knowledge to eliminate sarcoma cells at primary and metastatic sites by targeting critical pathways.

Preclinical Cancer Therapy Laboratory

The research focus of the Preclinical Cancer Therapy Laboratory is to provide mechanistic insight into cancer development and metastasis. Its goal is to understand the underlying mechanisms that will lead to successful development of effective targeted therapies to treat cancer patients. 

 
Education 
  • Assistant member, Earle A. Chiles Research Institute, Providence Cancer Institute, 2022
  • Postdoctoral fellow, Radiation Oncology, Duke University Medical Center, 2019
  • Doctor of Philosophy, Biochemistry, University of Mississippi Medical Center, 2015
  • Master of Science, Biomedical Engineering, Huazhong University of Science and Technology, 2010
  • Bachelor of Science, Biotechnology, Huazhong University of Science and Technology, 2008
Professional experience 
  • Senior scientist, Discovery Cell Therapy & Gene Editing, Juno Therapeutics, a Bristol Myers Squibb company, 2021-2022
  • Scientist, Discovery Cell Therapy & Gene Editing, Juno Therapeutics, a Bristol Myers Squibb company, Bristol Myers Squibb, 2019-2021
  • Postdoctoral associate, Radiation Oncology, Duke University Medical Center, 2015-2019
  • Research assistant, PhD Candidate, University of Mississippi Medical Center, 2012-2015
  • Research assistant, PhD Candidate, Southern Illinois University School of Medicine, 2010-2012
 
Memberships 
  • American Association for Cancer Research (AACR)
  • Federation of Clinical Immunology Societies
Awards
  • K22 grant, National Institutes of Health, 2020
  • Scholar-in-training Award, AACR Annual Meeting, 2018 
Publications 

Dr. Huang’s research is published in peer-reviewed scientific and medical journals. He has partnered with colleagues on various research projects.

View Dr. Huang’s full list of peer-reviewed publications.